Core Biopsy Needles Market to Reach USD 1718 million by 2034 at 6.8% CAGR
From USD 950 million in 2025 to USD 1718 million in 2034, a 6.8% compound annual rate.
Market findings and research announcements from the CDI research team. Showing 517–528 of 1113.
From USD 950 million in 2025 to USD 1718 million in 2034, a 6.8% compound annual rate.
From USD 12.5 billion in 2025 to USD 29.6 billion in 2034, a 10.21% compound annual rate.
Market reaches USD 86.73 billion by 2034, up from USD 17.5 billion in 2025, at a 19.54% CAGR.
Market reaches USD 21.65 billion by 2034, up from USD 10.85 billion in 2025, at a 8.05% CAGR.
Market reaches USD 247.04 billion by 2034, up from USD 58 billion in 2025, at a 17.5% CAGR.
Market reaches USD 48.4 billion by 2034, up from USD 15.8 billion in 2025, at a 13.2% CAGR.
Market reaches USD 5.6 billion by 2034, up from USD 1.85 billion in 2025, at a 12.26% CAGR.
Market reaches USD 232.7 billion by 2034, up from USD 132 billion in 2025, at a 6.5% CAGR.
From USD 22.4 million in 2025 to USD 410 million in 2034, a 38.4% compound annual rate.
Market reaches USD 51 billion by 2034, up from USD 18.2 billion in 2025, at a 12.03% CAGR.
Market reaches USD 3.15 billion by 2034, up from USD 1.5 billion in 2025, at a 8.76% CAGR.
From USD 1.9 billion in 2025 to USD 5.33 billion in 2034, a 11.89% compound annual rate.
For comment on a published finding, or to request the full study behind a release, contact the research team.